Current Drug Targets
Title:Editorial: Drug Targets and Biomarkers for Obstetric/Gynecologic/Reproductive Diseases
Volume: 18 Issue: 10
Author(s): Xueqiong Zhu*Shi-Wen Albert Jiang*
Affiliation:
- Department of Obstetrics and Gynecology The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University Wenzhou, Zhejiang 325027,China
- Department of Obstetrics and Gynecology The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University Wenzhou, Zhejiang 325027,China
Export Options
About this article
Cite this article as:
Zhu Xueqiong*, Jiang Albert Shi-Wen*, Editorial: Drug Targets and Biomarkers for Obstetric/Gynecologic/Reproductive Diseases, Current Drug Targets 2017; 18 (10) . https://dx.doi.org/10.2174/138945011810170710184519
DOI https://dx.doi.org/10.2174/138945011810170710184519 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Deleted in Colorectal Cancer (DCC) Pathfinding: Axon Guidance Gene Finally Turned Tumor Suppressor
Current Drug Targets Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders
Current Drug Safety Laparoscopic Approach for Surgical Staging in Early Endometrial Cancer
Current Women`s Health Reviews SUI-Current Medicinal Therapeutic Options
Current Women`s Health Reviews Mast Cells and Basophils: Trojan Horses of Conventional Lin- Stem/Progenitor Cell Isolates
Current Pharmaceutical Design Tamoxifen and its New Derivatives in Cancer Research
Recent Patents on Anti-Cancer Drug Discovery Folate-Linked Lipid-Based Nanoparticle for Targeted Gene Delivery
Current Drug Delivery Targeting Tumors Using Estrogen Receptor Ligand Conjugates
Current Cancer Drug Targets Cytostatic and Apoptotic Effects of DNMT and HDAC Inhibitors in Endometrial Cancer Cells
Current Pharmaceutical Design Molecular Dynamics in Esophageal Adenocarcinoma: Who’s in Control?
Current Cancer Drug Targets The Safety of Ovarian Preservation in Stage I Endometrial Endometrioid Adenocarcinoma Based on Propensity Score Matching
Combinatorial Chemistry & High Throughput Screening Irradiation Toxicity and Inflammatory Bowel Diseases (IBD): Review
Reviews on Recent Clinical Trials Regulation of EMT by KLF4 in Gastrointestinal Cancer
Current Cancer Drug Targets Spontaneous Pneumothorax
Current Respiratory Medicine Reviews Sentinel Lymph Node Mapping in Early Stage Endometrial Cancer Patients in Low-Resource Settings
Current Women`s Health Reviews Biological Activities, Mechanisms of Action and Biomedical Prospect of the Antitumor Ether Phospholipid ET-18-OCH3 (Edelfosine), A Proapoptotic Agent in Tumor Cells
Current Drug Metabolism Membrane Localization of Estrogen Receptors
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) PI3K Pathway Inhibitors: Better Not Left Alone
Current Pharmaceutical Design MMP-2 Selectivity in Hydroxamate-Type Inhibitors
Current Medicinal Chemistry The Effects of Tamoxifen on Immunity
Current Medicinal Chemistry